Anavex Life Sciences (AVXL) Upgraded by Zacks Investment Research to Hold

Anavex Life Sciences} stock has undergone multiple analysts rating changes in the recent past.  Anavex Life Sciences Upgraded by Zacks Investment Research on 10/13/2021. In a note to investors, the firm issued a new rating of Hold. The analysts previously had rating of Sell.

View More Anavex Life Sciences (AVXL) Upgraded by Zacks Investment Research to Hold